121 related articles for article (PubMed ID: 37403133)
1. Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver.
Hammoutene A; Tanguy M; Calmels M; Pravisani R; Albuquerque M; Casteleyn C; Slimani L; Sadoine J; Boulanger CM; Paradis V; Gilgenkrantz H; Rautou PE
Liver Int; 2023 Oct; 43(10):2309-2319. PubMed ID: 37403133
[TBL] [Abstract][Full Text] [Related]
2. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
[TBL] [Abstract][Full Text] [Related]
3. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
[TBL] [Abstract][Full Text] [Related]
4. Lack of endothelial autophagy does not impair liver regeneration after partial hepatectomy in mice.
Campreciós G; Anton A; Oncins A; Montironi C; Ruart M; Montañés R; García-Calderó H; García-Pagán JC; Hernández-Gea V
Liver Int; 2023 Oct; 43(10):2302-2308. PubMed ID: 37461159
[TBL] [Abstract][Full Text] [Related]
5. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice.
Islam SMT; Palanisamy AP; Chedister GR; Schmidt MG; Lewin DNB; Chavin KD
PLoS One; 2023; 18(5):e0284428. PubMed ID: 37167305
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
8. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
[TBL] [Abstract][Full Text] [Related]
9. Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy.
Valdecantos MP; Ruiz L; Pardo V; Castro-Sanchez L; García-Monzón C; Lanzón B; Rupérez J; Barbas C; Naylor J; Trevaskis JL; Grimsby J; Rondinone CM; Valverde ÁM
Sci Rep; 2018 Nov; 8(1):16461. PubMed ID: 30405191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis.
Ozawa Y; Tamura T; Owada Y; Shimizu Y; Kemmochi A; Hisakura K; Matsuzaka T; Shimano H; Isoda H; Ohkohchi N
World J Gastroenterol; 2018 Apr; 24(15):1622-1631. PubMed ID: 29686469
[TBL] [Abstract][Full Text] [Related]
12. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
13. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM
PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
Karimian G; Kirschbaum M; Veldhuis ZJ; Bomfati F; Porte RJ; Lisman T
PLoS One; 2015; 10(11):e0143121. PubMed ID: 26600128
[TBL] [Abstract][Full Text] [Related]
16. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
Valdecantos MP; Pardo V; Ruiz L; Castro-Sánchez L; Lanzón B; Fernández-Millán E; García-Monzón C; Arroba AI; González-Rodríguez Á; Escrivá F; Álvarez C; Rupérez FJ; Barbas C; Konkar A; Naylor J; Hornigold D; Santos AD; Bednarek M; Grimsby J; Rondinone CM; Valverde ÁM
Hepatology; 2017 Mar; 65(3):950-968. PubMed ID: 27880981
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
18. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
19. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats.
Picard C; Lambotte L; Starkel P; Sempoux C; Saliez A; Van den Berge V; Horsmans Y
J Hepatol; 2002 May; 36(5):645-52. PubMed ID: 11983448
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
